Theranostics, which focuses on patient-centered care, is emerging as a targeted, safe, and efficient pharmacotherapy. It consists of both diagnosis and treatment. It bridges the gap between conventional and personalised medicine. It is concerned with tailor-made treatment plans based on the uniqueness of each individual, resulting in the right drug for the right patient at the right time. Theranostics is heavily influenced by genetics. Theranostics offers a cost-effective and effective treatment protocol. Theranostics is built on pharmacogenetics, proteomics, and biomarker profiling. The role of Theranostics is interestingly appreciated at multi levels with special consideration in oncology wherein nano formulations in the form of liposomes, dendrimers, polymeric nanoparticles, metallic nanoparticles, quantum dots and carbon nanotubes play a very important role.
Read More- https://coherentmarketinsightsus.blogspot.com/2022/09/when-cancer-has-spread-metastasized-and.html
